Kogenta Nakamura
-
- Prostate Cancer Treatment and Research 22
- Prostate Cancer Diagnosis and Treatment 16
-
- Peptidase Inhibition and Analysis 7
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 7
-
- Bladder and Urothelial Cancer Treatments 15
-
- Antibiotics Pharmacokinetics and Efficacy 9
-
- Urologic and reproductive health conditions 8
-
- Urinary Tract Infections Management 7
- Co-authors
- Yoshiaki YamadaKenji ZennamiNobuaki HondaCharles J. RosserSatoshi AnaiTomohiro TakiShigeyuki AokiA K Malik
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kogenta Nakamura
83 papers receiving 837 citations
Peers
Comparison fields: 5 of 101
- Pulmonary and Respiratory Medicine 265
- Immunology 167
- Oncology 215
- Molecular Medicine 37
- Cancer Research 88
Countries citing papers authored by Kogenta Nakamura
This map shows the geographic impact of Kogenta Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kogenta Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kogenta Nakamura more than expected).
Fields of papers citing papers by Kogenta Nakamura
This network shows the impact of papers produced by Kogenta Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kogenta Nakamura. The network helps show where Kogenta Nakamura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kogenta Nakamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2020 | 1 | |
| 3 | 2018 | 6 | |
| 4 | 2014 | 1 | |
| 5 | 2013 | 16 | |
| 6 | 2011 | 3 | |
| 7 | 2011 | 1 | |
| 8 | 2009 | 8 | |
| 9 | 2009 | 23 | |
| 10 | 2008 | 15 | |
| 11 | Outcomes of men who present with elevated serum PSA (greater than 20 ng/mL)to an inner-city hospital | 2007 | 1 |
| 12 | 2007 | 4 | |
| 13 | 2007 | 3 | |
| 14 | 2007 | 19 | |
| 15 | 2006 | 10 | |
| 16 | 2006 | 33 | |
| 17 | 2006 | 4 | |
| 18 | 2003 | 2 | |
| 19 | 2002 | 3 | |
| 20 | Long term buserelin pretreatment for IVF in patients with endometriosis | 1992 | 1 |
About Kogenta Nakamura
Kogenta Nakamura is a scholar working on Molecular Medicine, Urology and Pulmonary and Respiratory Medicine, having authored 85 papers that have together received 858 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (22 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Bladder and Urothelial Cancer Treatments (15 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Urologic and reproductive health conditions (8 papers), Peptidase Inhibition and Analysis (7 papers), Antibiotic Resistance in Bacteria (7 papers) and Urinary Tract Infections Management (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (265 citations), Immunology (167 citations) and Oncology (215 citations). Kogenta Nakamura has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshiaki Yamada, Kenji Zennami, Nobuaki Honda, Charles J. Rosser, Satoshi Anai, Tomohiro Taki, Shigeyuki Aoki, A K Malik, S Mellouk and Daniel M. Gordon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.